Brief: Heron Therapeutics Announces Cost Reduction Plan And Restructuring

Heron Therapeutics

24/07/2023 14:25

July 24 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES COST REDUCTION PLAN AND
RESTRUCTURING
    * HERON THERAPEUTICS INC - EXPECTED OVERALL CASH SAVINGS OF
$75
MILLION THROUGH 2025
    * HERON THERAPEUTICS INC - HERON HAS CONDUCTED A CORPORATE
RESTRUCTURING, REDUCING COMPANY'S EMPLOYEE BASE BY 25%
    * HERON THERAPEUTICS INC -  COST REDUCTION PLAN WILL AIM TO
ACHIEVE PROFITABILITY IN LATE 2024
    * HERON THERAPEUTICS INC - EXPECTS TO INCUR NON-RECURRING
CASH
EXPENSES OF ABOUT $5.9 MILLION IN 2023
    * HERON THERAPEUTICS INC - NEW EXECUTIVE MANAGEMENT TEAM IN
PLACE

Source text for Eikon:  ID:nPn9NFNvFa 
Further company coverage:  HRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))